Fig. 4From: Vancomycin-resistant enterococci (VRE) screening and isolation in the general medicine ward: a cost-effectiveness analysisCost-effectiveness acceptability curve (CEAC) for cost-effectiveness thresholds from $0 to $50,000/QALYBack to article page